Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic Cholangiocarcinoma
Supriya K. Saha(Diamond Harbour Women's University), Nabeel Bardeesy(Broad Institute), Yasutaka Kato(Hokuto Hospital), Lei Shi(Broad Institute), Yusuke Mizukami(Asahikawa Medical College Hospital), John D. Gordan(University of California, San Francisco), Phuong Vu(Harvard University), Regina K. Egan(Harvard University), Lipika Goyal(Stanford Medicine), Benjamin P. Kleinstiver(Harvard University), Cyril H. Benes(Harvard University), Travis Sullivan(Lahey Medical Center), Jia-Chi Yeo(Massachusetts General Hospital), Leah J. Damon(Massachusetts General Hospital), Mortada S. Najem(Massachusetts General Hospital), James T. Webber(UCSF Helen Diller Family Comprehensive Cancer Center), Roger L. Jenkins(Lahey Hospital and Medical Center), Kevan M. Shokat(Howard Hughes Medical Institute), Ultan McDermott(AstraZeneca (United Kingdom)), Andrew S. Liss(Northwestern University), Kimberly Rieger‐Christ(Lahey Hospital and Medical Center), Mathew J. Garnett(Wellcome Sanger Institute), Andrew X. Zhu(Icahn School of Medicine at Mount Sinai), Patricia Greninger(Harvard University), Cristina R. Ferrone(Brigham and Women's Hospital), J. Keith Joung(Massachusetts General Hospital), Rebecca S. Levin(University of California, San Francisco), Aram F. Hezel(University of Rochester Medical Center)
Cited by 163
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
|Nature Biotechnology|2013|3.3k
CRISPR-Cas systems for editing, regulating and targeting genomes
|Nature Biotechnology|2014|3.2k
Efficient genome editing in zebrafish using a CRISPR-Cas system
|Nature Biotechnology|2013|3k